2'-Amino-2'-deoxy--D-arabinouridine manufacturers
|
| | 2'-Amino-2'-deoxy--D-arabinouridine Basic information |
| Product Name: | 2'-Amino-2'-deoxy--D-arabinouridine | | Synonyms: | 2'-Amino-2'-deoxy--D-arabinouridine;2'-Amino-2'-deoxy-beta-D-arabinouridine;2’-Amino-2’-deoxy-b-D-arabinouridine;2’-Amino-2’-deoxy-β-D-arabinouridine;2,4(1H,3H)-Pyrimidinedione, 1-(2-amino-2-deoxy-β-D-arabinofuranosyl)-;2’-Amino-2’-deoxy-beta-D-arabinouridine;1-((2R,3S,4S,5R)-3-amino-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione | | CAS: | 68115-81-1 | | MF: | C9H13N3O5 | | MW: | 243.22 | | EINECS: | | | Product Categories: | | | Mol File: | 68115-81-1.mol |  |
| | 2'-Amino-2'-deoxy--D-arabinouridine Chemical Properties |
| density | 1.555±0.06 g/cm3(Predicted) | | pka | 9.39±0.10(Predicted) |
| | 2'-Amino-2'-deoxy--D-arabinouridine Usage And Synthesis |
| Uses | 2’-Amino-2’-deoxy-β-D-arabinouridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | | References | [1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
| | 2'-Amino-2'-deoxy--D-arabinouridine Preparation Products And Raw materials |
|